Related Experiment Video
Updated: Apr 28, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2
Maria D Cirnaru1, Antonella Marte2, Elisa Belluzzi3
1Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute University Milan, Italy ; Department of Molecular and Cellular Pharmacology, National Research Council, Neuroscience Institute Milan, Italy.
Abstract:
Mutations in Leucine-rich repeat kinase 2 gene (LRRK2) are associated with familial and sporadic Parkinson's disease (PD). LRRK2 is a complex protein that consists of multiple domains executing several functions, including GTP hydrolysis, kinase activity, and protein binding. Robust evidence suggests that LRRK2 acts at the synaptic site as a molecular hub connecting synaptic vesicles to cytoskeletal elements via a complex panel of protein-protein interactions. Here we investigated the impact of pharmacological inhibition of LRRK2 kinase activity on synaptic function. Acute treatment with LRRK2 inhibitors reduced the frequency of spontaneous currents, the rate of synaptic vesicle trafficking and the release of neurotransmitter from isolated synaptosomes. The investigation of complementary models lacking LRRK2 expression allowed us to exclude potential off-side effects of kinase inhibitors on synaptic functions. Next we studied whether kinase inhibition affects LRRK2 heterologous interactions. We found that the binding among LRRK2, presynaptic proteins and synaptic vesicles is affected by kinase inhibition. Our results suggest that LRRK2 kinase activity influences synaptic vesicle release via modulation of LRRK2 macro-molecular complex.
Insights
Inhibition of Leucine-rich repeat kinase 2 (LRRK2) kinase activity impacts synaptic function and neurotransmitter release. This modulation affects LRRK2
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Mutations in the Leucine-rich repeat kinase 2 (LRRK2) gene are linked to Parkinson's disease (PD).
- LRRK2 is a complex protein involved in GTP hydrolysis, kinase activity, and protein binding, acting as a molecular hub at synapses.
- LRRK2 connects synaptic vesicles to cytoskeletal elements through protein-protein interactions.
Purpose of the Study:
- To investigate the effect of pharmacological LRRK2 kinase inhibition on synaptic function.
- To determine if kinase inhibition alters LRRK2's interactions with other proteins at the synapse.
Main Methods:
- Acute treatment of isolated synaptosomes with LRRK2 kinase inhibitors.
- Assessment of spontaneous currents, synaptic vesicle trafficking, and neurotransmitter release.
- Investigation using cell models with LRRK2 gene knockout to rule out off-target effects.
Main Results:
- LRRK2 inhibition reduced spontaneous current frequency and neurotransmitter release.
- Synaptic vesicle trafficking rates were decreased following LRRK2 inhibition.
- Kinase inhibition altered the binding of LRRK2 with presynaptic proteins and synaptic vesicles.
Conclusions:
- LRRK2 kinase activity plays a crucial role in regulating synaptic vesicle release.
- Inhibition of LRRK2 kinase activity impacts synaptic function by modulating LRRK2's macromolecular complex.
- These findings provide insights into the role of LRRK2 in synaptic transmission and Parkinson's disease.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Lysosomal Hydrolases

